Volume 120, Issue 4 pp. 769-775
Cancer Genetics

Elucidation of a protein signature discriminating six common types of adenocarcinoma

Gregory C. Bloom

Gregory C. Bloom

Biostatistics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Search for more papers by this author
Steven Eschrich

Steven Eschrich

Biostatistics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Search for more papers by this author
Jeff X. Zhou

Jeff X. Zhou

Large Scale Biology Corporation, Germantown, MD

National Institutes of Health, Rockville, MD

Search for more papers by this author
Domenico Coppola

Domenico Coppola

Biostatistics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Search for more papers by this author
Timothy J. Yeatman

Corresponding Author

Timothy J. Yeatman

Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Department of Surgery, University of South Florida College of Medicine, Tampa, FL

Department of Pathology, University of South Florida College of Medicine, Tampa, FL

Fax: +813-745-1433.

H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, SRB-2, Tampa, FL 33612, USASearch for more papers by this author
First published: 27 December 2006
Citations: 32

Abstract

Pathologists are commonly facing the problem of attempting to identify the site of origin of a metastatic cancer when no primary tumor has been identified, yet few markers have been identified to date. Multitumor classifiers based on microarray based RNA expression have recently been described. Here we describe the first approximation of a tumor classifier based entirely on protein expression quantified by two-dimensional gel electrophoresis (2DE). The 2DE was used to analyze the proteomic expression pattern of 77 similarly appearing (using histomorphology) adenocarcinomas encompassing 6 types or sites of origin: ovary, colon, kidney, breast, lung and stomach. Discriminating sets of proteins were identified and used to train an artificial neural network (ANN). A leave-one-out cross validation (LOOCV) method was used to test the ability of the constructed network to predict the single held out sample from each iteration with a maximum predictive accuracy of 87% and an average predictive accuracy of 82% over the range of proteins chosen for its construction. These findings demonstrate the use of proteomics to construct a highly accurate ANN-based classifier for the detection of an individual tumor type, as well as distinguishing between 6 common tumor types in an unknown primary diagnosis setting. © 2006 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.